Acetaminophen (Paracetamol) updated on 09-20-2024

Childhood asthma

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S18602
R79074
Liew, 2021 Asthma Diagnosis - Maternal report according to the International Study of Asthma and Allergies in Childhood (ISAAC) core questionnaire - At 3 to 4 years of age during pregnancy (anytime or not specified) retrospective cohort unexposed (general population or NOS) Adjustment: Yes Paracetamol use: maternal ITW/questionnaires after pregnancy 1.38 [0.96;1.98] 47/393   71/808 118 393
ref
S18558
R79329
Malaeb, 2021 Diagnosed asthma - Diagnosed asthma with symptoms (chronic wheezing, cough, and dyspnea), and an affirmative answer to the question 'did your doctor ever tell you that your child has asthma?' - Mean age 10.3 years old during pregnancy (anytime or not specified) case control unexposed (general population or NOS) Adjustment: Yes Paracetamol use: maternal ITW/questionnaires after pregnancy 4.66 [1.92;11.30] -/-   0/- - -
ref
S18510
R78649
Shaheen (Controls unexposed, general pop), 2019 Childhood asthma/wheeze - At 6 years of age (ICD-10 (J45 and J46) and asthma prescribed medications for children < 4.5 years; ICD-10 (J45 and J46) or asthma prescribed medications for children > 4.5 years) during pregnancy (anytime or not specified) population based cohort retrospective unexposed (general population or NOS) Adjustment: Yes Paracetamol use: prescription or medical files 1.46 [1.23;1.72] 194/-   -/- - -
ref
S18511
R78652
Shaheen (Controls unexposed, sibling), 2019 Childhood asthma/wheeze - At 4 years of age (ICD-10 (J45 and J46) and asthma prescribed medications for children < 4.5 years; ICD-10 (J45 and J46) or asthma prescribed medications for children > 4.5 years) during pregnancy (anytime or not specified) population based cohort retrospective sibling excluded Adjustment: Yes Paracetamol use: prescription or medical files 0.80 [0.50;1.29]
excluded (control group)
-/-   -/- - -
ref
S18579
R78948
Magnus (Controls exposed to ibuprofen), 2016 Current asthma (three positive criteria reported in the 7-year questionnaire: a positive report of ever asthma, experiencing asthma symptoms during the past year and using medications for asthma in the past year) - At 7 years (Parental reported) during pregnancy (anytime or not specified) prospective cohort exposed to other treatment, sick excluded Adjustment: No Paracetamol use: maternal ITW/questionnaires during pregnancy 1.23 [0.77;1.96] C
excluded (control group)
647/10,608   19/378 666 10,608
ref
S18578
R78945
Magnus (Controls unexposed, NOS), 2016 Current asthma (three positive criteria reported in the 7-year questionnaire: a positive report of ever asthma, experiencing asthma symptoms during the past year and using medications for asthma in the past year) - At 7 years (Parental reported) during pregnancy (anytime or not specified) prospective cohort unexposed (general population or NOS) Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy 1.27 [1.09;1.47] 405/7,240   386/9,905 791 7,240
ref
S18517
R78683
Andersen, 2012 Asthma in offspring (at least two prescriptions of both a β-agonist and an inhaled glucocorticoid and/or a hospital diagnosis of asthma) - Median follow-up time 6.8 years during pregnancy (anytime or not specified) population based cohort retrospective unexposed (general population or NOS) Adjustment: Yes Negative controls: confusion biais +++ Paracetamol use: prescription or medical files 1.35 [1.17;1.57] 176/976   24,330/196,084 24,506 976
ref
S18526
R79179
Persky, 2008 Asthma diagnosis - Maternal reported - By the age of 1 year during pregnancy (anytime or not specified) retrospective cohort unexposed (general population or NOS) Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy 1.60 [0.40;6.40] -/240   -/103 - 240
ref
S18534
R78813
Rebordosa b, 2008 Physician-diagnosed asthma/bronchitis (Maternal reported) - At 7-year-old during pregnancy (anytime or not specified) prospective cohort unexposed (general population or NOS) Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy 1.15 [1.02;1.29] 886/6,752   644/5,981 1,530 6,752
ref
Total 7 studies 1.34 [1.18;1.52] 26,945 15,601
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Liew, 2021Liew, 2021 1.38[0.96; 1.98]1183939%ROB confusion: seriousROB selection: unclearROB classification: criticalROB missing: moderateROB mesure: criticalROB reporting: moderate Malaeb, 2021Malaeb, 2021 4.66[1.92; 11.30]--2%ROB confusion: seriousROB selection: criticalROB classification: criticalROB missing: moderateROB mesure: criticalROB reporting: critical Shaheen (Controls unexposed, general pop), 2019Shaheen, 2019 1 1.46[1.23; 1.72]--20%ROB confusion: moderateROB selection: criticalROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Magnus (Controls unexposed, NOS), 2016Magnus, 2016 2 1.27[1.09; 1.47]7917,24022%ROB confusion: lowROB selection: lowROB classification: moderateROB missing: criticalROB mesure: criticalROB reporting: moderate Andersen, 2012Andersen, 2012 1.35[1.17; 1.57]24,50697622%ROB confusion: criticalROB selection: lowROB classification: moderateROB missing: unclearROB mesure: moderateROB reporting: moderate Persky, 2008Persky, 2008 1.60[0.40; 6.40]-2401%ROB confusion: seriousROB selection: lowROB classification: moderateROB missing: moderateROB mesure: criticalROB reporting: moderate Rebordosa b, 2008Rebordosa b, 2008 1.15[1.02; 1.29]1,5306,75224%ROB confusion: moderateROB selection: lowROB classification: moderateROB missing: moderateROB mesure: criticalROB reporting: moderate Total (7 studies) I2 = 59% 1.34[1.18; 1.52]26,94515,6010.510.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, general pop; 2: Controls unexposed, NOS;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.29[1.19; 1.40]26,94515,60121%NALiew, 2021 Shaheen (Controls unexposed, general pop), 2019 Magnus (Controls unexposed, NOS), 2016 Andersen, 2012 Persky, 2008 Rebordosa b, 2008 6 case control studiescase control studies 4.66[1.92; 11.30]-- -NAMalaeb, 2021 1 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.34[1.18; 1.52]26,94515,60159%NALiew, 2021 Malaeb, 2021 Shaheen (Controls unexposed, general pop), 2019 Magnus (Controls unexposed, NOS), 2016 Andersen, 2012 Persky, 2008 Rebordosa b, 2008 7 Tags Adjustment   - Yes  - Yes 1.34[1.18; 1.52]26,94515,60159%NALiew, 2021 Malaeb, 2021 Shaheen (Controls unexposed, general pop), 2019 Magnus (Controls unexposed, NOS), 2016 Andersen, 2012 Persky, 2008 Rebordosa b, 2008 7 Negative controls   - confusion biais +++  - confusion biais +++ 1.35[1.17; 1.56]24,506976 -NAAndersen, 2012 1 Paracetamol use   - maternal ITW/questionnaires after p ...  - maternal ITW/questionnaires after pregnancy 2.36[0.72; 7.73]11839384%NALiew, 2021 Malaeb, 2021 2   - maternal ITW/questionnaires during ...  - maternal ITW/questionnaires during pregnancy 1.20[1.09; 1.31]2,32114,2320%NAMagnus (Controls unexposed, NOS), 2016 Persky, 2008 Rebordosa b, 2008 3   - prescription or medical files  - prescription or medical files 1.40[1.25; 1.56]24,5069760%NAShaheen (Controls unexposed, general pop), 2019 Andersen, 2012 2 All studiesAll studies 1.34[1.18; 1.52]26,94515,60159%NALiew, 2021 Malaeb, 2021 Shaheen (Controls unexposed, general pop), 2019 Magnus (Controls unexposed, NOS), 2016 Andersen, 2012 Persky, 2008 Rebordosa b, 2008 70.510.01.0

Publication bias and p-hacking diagnosis

funnel plot
0.0-1.82.00.8490.000Liew, 2021Malaeb, 2021Shaheen (Controls unexposed, general pop), 2019Magnus (Controls unexposed, NOS), 2016Andersen, 2012Persky, 2008Rebordosa b, 2008

Asymetry test p-value = 0.0996 (by Egger's regression)

slope=0.1063 (0.0855); intercept=1.8455 (0.9146); t=2.0178; p=0.0996

p values plot
0.01.00.01.0

Sub-groups analysis using all included studies

excluded 18579, 18511

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.34[1.18; 1.52]27,13015,60159%NALiew, 2021 Malaeb, 2021 Shaheen (Controls unexposed, general pop), 2019 Magnus (Controls unexposed, NOS), 2016 Andersen, 2012 Persky, 2008 Rebordosa b, 2008 7 exposed to other treatment, sick controlsexposed to other treatment, sick controls 1.23[0.77; 1.96]66610,608 -NAMagnus (Controls exposed to ibuprofen), 2016 1 siblingssiblings 0.80[0.50; 1.28]-- -NAShaheen (Controls unexposed, sibling), 2019 10.510.01.0

Umbrella review (other published meta-analyses)

Published MAControlPeriodTE95% CIn exposedkI2 Cheelo (Asthma in childhood (established by d ...Cheelo (Asthma in childhood (established by doctor diagnosis, medical records or structured questionnaires)) 1.49[1.37; 1.63]0%-Wwhatever (meta-analysis)T2-T32nd and/or 3rd trimesterstudies TTT3 Cheelo (Asthma in childhood (established by d ...Cheelo (Asthma in childhood (established by doctor diagnosis, medical records or structured questionnaires)) 1.39[1.01; 1.91]64%-Wwhatever (meta-analysis)T11st trimesterstudies TTT5 Cheelo (Asthma in childhood (established by d ...Cheelo (Asthma in childhood (established by doctor diagnosis, medical records or structured questionnaires)) 1.17[1.04; 1.31]0%-Wwhatever (meta-analysis)T33rd trimesterstudies TTT2 Baranska (Asthma in children)Baranska (Asthma in children) 1.21[1.01; 1.45]79%-Wwhatever (meta-analysis)T11st trimesterstudies TTT5 Baranska (Asthma in children)Baranska (Asthma in children) 1.10[1.01; 1.19]0%-Wwhatever (meta-analysis)T22nd trimesterstudies TTT3 Baranska (Asthma in children)Baranska (Asthma in children) 1.18[1.11; 1.26]0%-Wwhatever (meta-analysis)T33rd trimesterstudies TTT4 Baranska (Asthma in children)Baranska (Asthma in children) 1.34[1.22; 1.48]65%-Wwhatever (meta-analysis)Anyduring pregnancy (anytime or not specified)studies TTT10 Fan (Child asthma risk (asthma/wheeze together))Fan (Child asthma risk (asthma/wheeze together)) 1.19[1.12; 1.27]41%-Wwhatever (meta-analysis)Anyduring pregnancy (anytime or not specified)studies TTT13 Fan (Child asthma risk (asthma/wheeze together))Fan (Child asthma risk (asthma/wheeze together)) 1.21[1.14; 1.28]0%-Wwhatever (meta-analysis)T11st trimesterstudies TTT6 Fan (Child asthma risk (asthma/wheeze together))Fan (Child asthma risk (asthma/wheeze together)) 1.13[1.04; 1.23]33%-Wwhatever (meta-analysis)T2-T32nd and/or 3rd trimesterstudies TTT7 metaPregmetaPreg 1.34[1.18; 1.52]59%15,601----Liew, 2021 Malaeb, 2021 Shaheen (Controls unexposed, general pop), 2019 Magnus (Controls unexposed, NOS), 2016 Andersen, 2012 Persky, 2008 Rebordosa b, 2008 70.510.01.0